AbbVie vs Xiaomi: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. Xiaomi was founded in 2010 by Lei Jun, Lin Bin and is led by Lei Jun.
Company facts
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
Xiaomi
Lei Jun
Lei Jun founded Xiaomi in 2010 and is its chairman and CEO. He set the company's early strategy of selling well-specified phones online at low prices, built the MIUI user community, and later led Xiaomi's 2018 Hong Kong listing.
Lin Bin
Lin Bin co-founded Xiaomi in 2010 and served as its president, overseeing early phone development and supply-chain relationships. He handed the president role to others in 2019 and continued as vice chairman of the board.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
Xiaomi
- Lei Jun2010–present
Founder, Chairman and CEO
Sets Xiaomi's product and ecosystem strategy and leads the EV business.
Source - Lin Bin2010–present
Co-founder and Vice Chairman
Co-founded Xiaomi with Lei Jun and served as president during its early growth before moving to the vice chairman role.
Source - Lu Weibing2022–present
President
Runs day-to-day operations of the group, having earlier led the Redmi brand and international business.
Source
Timeline: AbbVie and Xiaomi side by side
2010Xiaomi
Xiaomi Founded
Lei Jun and seven co-founders establish Xiaomi in Beijing and release the MIUI Android software.
2011Xiaomi
Mi 1 Launches
Xiaomi launches its first smartphone, sold online.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2014Xiaomi
India Entry and $45B Valuation
Xiaomi enters India and raises funding at a reported $45B valuation.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2018Xiaomi
Hong Kong IPO
Xiaomi lists on the Hong Kong Stock Exchange under stock code 1810 with a weighted voting rights structure.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2021Xiaomi
EV Entry Announced
Xiaomi announces it will build electric vehicles and sets up a dedicated EV subsidiary.
2021Xiaomi
Acquired DeepMotion
Xiaomi acquired DeepMotion for $77 million. Autonomous-driving technology company acquired to support Xiaomi's EV program.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2024Xiaomi
SU7 Launch
Xiaomi launches the SU7 electric sedan in March 2024 and begins deliveries.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2025Xiaomi
Record Year and YU7 Launch
Xiaomi launches the YU7 SUV, delivers 411,082 vehicles, and reports FY2025 revenue of ~$63.6B (RMB457.3B).
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
2026Xiaomi
Memory Costs Hit Profit
Q1 revenue falls 10.9% to ~$13.8B (RMB99.1B) and Q2 revenue falls 6.1% to ~$15.1B (RMB108.9B) as memory-chip costs squeeze margins.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
Questions about AbbVie vs Xiaomi
Who is the CEO of AbbVie Inc. and Xiaomi Corp.?
AbbVie Inc. is led by Robert A. Michael and Xiaomi Corp. is led by Lei Jun. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs Xiaomi Corp.?
Xiaomi Corp. was founded in 2010 — 3 years before AbbVie Inc., which was founded in 2013. Xiaomi Corp.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to Xiaomi Corp.?
AbbVie Inc. employs approximately 57,000 people, while Xiaomi Corp. employs approximately 56,531. AbbVie Inc. has the larger workforce at 57,000 employees, compared to Xiaomi Corp.'s 56,531. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and Xiaomi Corp. headquartered?
AbbVie Inc. is headquartered in United States and Xiaomi Corp. is headquartered in China. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded AbbVie Inc. and Xiaomi Corp.?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Xiaomi Corp. was founded by Lei Jun, Lin Bin.
Which company has a longer operating history — AbbVie Inc. or Xiaomi Corp.?
Xiaomi Corp. has been operating for approximately 16 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs Xiaomi overview